products, technologies and practices in the treatment of surgical, traumatic or disease induced wounds spanning any and all organ systems
Skin replacements and substitutes (see image at right: Apligraf by Organogenesis, Inc.) compete in the severe burn, venous leg ulcer, and the diabetic foot ulcer markets where their high cost is offset by their ability to save lives and/or preserve limbs from amputation. These products have taken some time to demonstrate clinical effectiveness and to [...]
The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:
Source: MedMarket Diligence, LLC; [...]
(This is drawn in part from the Executive Summary of MedMarket Diligence's "Worldwide Wound Management Market, 2008-2017", Report #S247.)
The skin is our protection from the environment. Far from being just a physical barrier, the skin is a complex organ, protecting our bodies from chemical, biological and physical insult, keeping organs and tissues in their place, [...]
(Below is an excerpt from "Surgical Sealants, Glues and Wound Closure Worldwide Market, 2009-2013.")
Natural hemostats such as gelatin, collagen and thrombin were first developed as hemostatic agents, followed by mixes and fibrin sealants. More recently, companies have introduced synthetic sealants and hemostats that accelerate the process of blood clotting and provide a stronger seal that [...]
Because skin ulcers, which may encompass pressure ulcers, arterial ulcers, venous ulcers and diabetic ulcers, have a tendency to be slow-healing and therefore chronic conditions, their management can be costly in terms of both direct and indirect costs. The direct cost of changing multiple bandages becomes compounded when non-healing skin ulcers develop other clinical sequellae, [...]
The use of autologous, allogeneic and xenogeneic cells and tissues, the use of biomaterials, cell scaffolding and other approaches to tissue repair and regeneration has become part of arsenal of a number of clinical specialties, with high caseload and market revenue in these areas. In particular, orthopedics and skin applications are well established. And, while [...]
Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical [...]
The global wound management market is comprised of very diverse products spanning many different wound dressing types, growth factors, tissue engineering and a growing portfolio of physical therapies.
Growth in wound management product revenues varies considerably, and will result in different market distribution.
Product Category
2008
% total wound market
2017
% total wound market
Film
[...]
Clinical protocols for the treatment of specific wounds can vary considerably from country to country. Venous stasis ulcers, which account for approximately 4% of wounds and 75% of leg ulcers, are treated with short stretch compression bandages in Germany, elastic adhesive bandages in Italy, high compression bandages in France and multi-layer compression systems in the [...]
The market for wound management includes many products that fall into more than one category. For summary purposes, product-based revenues can be assembled into categories including fabric dressings, first aid dressings, dressings and internal wound management products for surgery, advanced wound management products, active pharmaceutical wound care products, tissue engineering, physical therapies for wound care, [...]
Contact:
